Editorial

Area of Science:

• Dermatology
• Medical Technology
• Healthcare Policy
• Clinical Trials
• Rare Diseases

Background:

• Advances in dermatoscopes enhance diagnostic accuracy for pigmented lesions.
• Healthcare system restructuring impacts medical practice patterns and access to specialized procedures like Mohs' micrographic surgery.
• Decreased dermatology trainees necessitate alternative care models for underserved areas, such as telemedicine.

Purpose of the Study:

• To delineate dermatoscopic features differentiating acral lentiginous melanoma in situ from melanocytic nevi.
• To explore the role of telemedicine in addressing healthcare access challenges in dermatology.
• To review early-phase clinical trial processes and the management of calciphylaxis.

Main Methods:

• Dermatoscopic examination and analysis of pigmented lesions.
• Review of healthcare restructuring impacts on dermatology practice and training.
• Discussion of telemedicine applications and regulatory processes for new therapies.
• Presentation of Phase 1 clinical trial methodologies and calciphylaxis case reports.

Main Results:

• Dermatoscopy aids in distinguishing benign pigmented lesions from melanoma.
• Telemedicine is proposed as a solution for healthcare access in underserved regions.
• Phase 1 clinical trials are crucial for initial drug safety and efficacy assessment.
• Calciphylaxis presents with distinctive, severe manifestations requiring careful management.

Conclusions:

• Dermatoscopy is a valuable tool for dermatologists in lesion diagnosis.
• Telemedicine offers potential solutions to dermatology workforce and access issues.
• Understanding early drug development and rare diseases like calciphylaxis is essential for clinical practice.